Positron Emission Tomography (PET) scans rely on a specialized tracer to visualize metabolic activity within the body. This tracer, 2-deoxyglucose, is a modified sugar molecule that is taken up in areas of high metabolic demand. By introducing FDG into the bloodstream and tracking its distribution through PET scanners, clinicians can detect a wide